Avian Influenza Studies In Lebanon
NCT01107262 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 250
Last updated 2011-10-27
Summary
The highly pathogenic avian influenza (HPAI) H5N1 virus arrived in the Middle East in 2005 and has since established itself in local domestic birds and is now considered endemic in several Middle Eastern countries.Few studies indicate the presence of low pathogenicity avian influenza (LPAI) viruses of the H9 type among Lebanese poultry and wild birds. These studies also provide some evidence suggesting that humans exposed to these sick birds are showing elevated antibody titers against these LPAI H9 viruses.
This study will focus on the following objectives:
* To determine the seroprevalence of AI in poultry-exposed and non-exposed human populations.
* To identify risk factors associated with AI infections in occupationally-exposed poultry workers.
* To conduct nation-wide cross-sectional surveillance for AI viruses among domestic birds in low biosecurity farms and backyard flocks.
Conditions
- Avian Influenza
- Virus Diseases
Sponsors & Collaborators
-
American University of Beirut Medical Center
collaborator OTHER -
St. Jude Children's Research Hospital
lead OTHER
Principal Investigators
-
Mohammad Ghazi Kayali, Ph.D, MPH · St. Jude Children's Research Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-07-31
- Primary Completion
- 2010-12-31
- Completion
- 2010-12-31
Countries
- United States
- Lebanon
Study Locations
More Related Trials
-
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
NCT00984451 ·Status: COMPLETED
-
Safety Study of Avian Flu Vaccine
NCT00408109 ·Status: COMPLETED ·Phase: PHASE1
-
Cell-Mediated Immune Responses to Influenza A/H5N1 Vaccine
NCT00311727 ·Status: COMPLETED ·Phase: NA
-
Safety, Tolerability and Immunogenicity of a Plant-Made H1 VLP Influenza Vaccine in Adults
NCT01302990 ·Status: COMPLETED ·Phase: PHASE1
-
A Retrospective, Observational Registry of Participants With Avian Influenza Infection
NCT02743676 ·Status: COMPLETED
-
Evaluating the Safety and Immune Response to an H5N1 Influenza Vaccine in People Who Have Previously Received an H5N1 or H7N3 Influenza Vaccine and in People Who Have Never Received a Live Attenuated Influenza Vaccine
NCT01443663 ·Status: COMPLETED ·Phase: PHASE1
-
Zoonotic Influenza Surveillance in Belgium
NCT05827601 ·Status: UNKNOWN
-
China Case Control Avian Influenza
NCT00428753 ·Status: COMPLETED
-
Zoonotic Influenza Infections of Swine Origin at Ohio Agricultural Fairs
NCT02124096 ·Status: COMPLETED
-
Safety and Immunogenicity of Live Influenza A Vaccine for Avian Influenza H7N7
NCT00922259 ·Status: COMPLETED ·Phase: PHASE1
-
The Effectiveness of Influenza Vaccine Among Health Care Workers in a Hospital Setting.
NCT00265161 ·Status: COMPLETED
-
A/H5N1 Vaccine in Healthy Children Aged 2-9 Years
NCT00133536 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Immunogenicity and Safety of Inactivated H1N1 Swine-origin Influenza Monovalent Vaccine in Immunocompromised Children and Young Adults
NCT01000571 ·Status: COMPLETED
-
B-cell Immunity to Influenza (SLVP017) - Years 2 (2010) & 3 (2011)
NCT03020498 ·Status: COMPLETED ·Phase: PHASE4
-
Vaccine for Prevention of Bird Flu
NCT00776711 ·Status: COMPLETED ·Phase: PHASE1
-
Inactivated Influenza A/H5N1 Vaccine in the Elderly
NCT00230750 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety of and Immune Response to a Bird Flu Virus Vaccine (H9N2) in Healthy Adults (Study A)
NCT00110279 ·Status: COMPLETED ·Phase: PHASE1
-
Screening for LID Clinical Studies Unit Healthy Volunteer Protocols
NCT01386424 ·Status: RECRUITING
-
Systems Biology of Influenza A (H5N1) Virus Monovalent Vaccine With and Without Adjuvant System 03 (AS03)
NCT01910519 ·Status: COMPLETED ·Phase: PHASE2
-
Influenza A H3N2 Human Challenge Study in Healthy Adult Volunteers
NCT02594189 ·Status: COMPLETED ·Phase: PHASE1
-
Influenza Challenge Study in Healthy Volunteers
NCT02746211 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Prospective Study of AI H5N1 in China
NCT00428493 ·Status: COMPLETED
-
PET-CT Scans in Healthy Volunteers After Flu Vaccination
NCT00769002 ·Status: TERMINATED ·Phase: NA
-
Safety, Tolerability, Efficacy and Immunogenicity of an Influenza A Vaccine (FP-01.1) in Healthy Volunteers Following Virus Challenge
NCT02071329 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Immunogenicity of BPL-1357, A BPL-Inactivated, Whole-Virus, Universal Influenza Vaccine
NCT05027932 ·Status: COMPLETED ·Phase: PHASE1